Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GlaxoSmithKline: Offering Stable And Juicy Dividend Yield
Seeking Alpha
Saturday, November 9, 2013 - 12:34pm
tags:
GSK
Eli Lilly Goes Down The Hill As Patents Expire
Seeking Alpha
Saturday, November 9, 2013 - 12:33pm
tags:
Eli Lilly, patents
Pfizer says organ transplant drug fails in study
Yahoo/AP
Saturday, November 9, 2013 - 12:31pm
tags:
Rapamune, Pfizer, organ transplants
Soliris® (eculizumab) Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with atypical Hemolytic Uremic Syndrome (aHUS)
Yahoo/BusinessWire
Saturday, November 9, 2013 - 12:29pm
tags:
Soliris, atypical hemolytic uremic syndrome, Alexion
Key Takeaways From Vivus' Bad Quarter
Motley Fool
Saturday, November 9, 2013 - 12:26pm
tags:
Vivus, earnings
Boom Or Bubble? Insiders Like The Look Of These 3 Biotech Stocks
The Street
Saturday, November 9, 2013 - 12:25pm
tags:
BioSpecifics Technologies, MannKind, Acadia
Hemispherx Biopharma Announces Financial Results for the Three Months Ended September 30, 2013
Yahoo/Globe Newswire
Saturday, November 9, 2013 - 12:22pm
tags:
Hemispherx Biopharma, earnings
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests
Yahoo/PR NewsWire
Saturday, November 9, 2013 - 12:21pm
tags:
Santarus, Salix, M&A
A Busy Day of Layoffs in Pharma
Motley Fool
Friday, November 8, 2013 - 12:00pm
tags:
layoffs, Novartis, Bristol-Myers Squibb, Ariad Pharmaceuticals
Geron's Promising News Poses No Threat To Incyte
Seeking Alpha
Friday, November 8, 2013 - 11:59am
tags:
Geron, Incyte, stem cells, imetelstat
Amarin Appeals FDA Rescission Of Special Protocol Agreement
Pharmalot
Friday, November 8, 2013 - 11:57am
tags:
Amarin, FDA
India Cracks Down: Sun Pharma Clinical Work At Lab Is Halted
Pharmalot
Friday, November 8, 2013 - 11:56am
tags:
India, Sun Pharma
3 Biotechs on the Move This Week
Motley Fool
Friday, November 8, 2013 - 11:55am
tags:
Immunogen, IMGN901, Immunomedics, Takeda, imetelstat, Geron
After Bristol-Myers R&D cuts, will AstraZeneca amp up its share of diabetes JV?
Fierce Pharma
Friday, November 8, 2013 - 11:11am
tags:
AstraZeneca, Bristol-Myers Squibb, diabetes
FDA staffers throw cold water on Sanofi's Lemtrada hopes
Fierce Pharma
Friday, November 8, 2013 - 11:10am
tags:
FDA, Sanofi, Lemtrada, MS, multiple sclerosis
Report: Danaher, Blackstone join forces in hunt for J&J diagnostics unit
Mass Device
Friday, November 8, 2013 - 11:03am
tags:
JNJ, diagnostics, M&A, Ortho Clinical Diagnostics
Covidien scores Q4, FY2013 earnings beats
Mass Device
Friday, November 8, 2013 - 11:02am
tags:
Covidien, earnings, devices
Janssen Pleads Guilty to Selling Risperdal Off-Label
Bloomberg
Friday, November 8, 2013 - 10:51am
tags:
Janssen, off-label, Risperdal, JNJ
Novo Nordisk And The Danish Delusion
Forbes
Friday, November 8, 2013 - 10:50am
tags:
Novo Nordisk, Denmark, Eli Lilly, diabetes, insulin
Boehringer to bid for poultry vaccine maker Lohmann - sources
Yahoo/Reuters
Friday, November 8, 2013 - 10:48am
tags:
Boehringer, animal health, Lohmann Animal Health, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.